Conduction system abnormalities in patients with obstructive hypertrophic cardiomyopathy following septal reduction interventions

American Journal of Cardiology

Volumn 93, Issue 2, 2004, Pages 171-175

  Qin, Jian Xin ^a   Shiota, Takahiro ^a   Lever, Harry M ^a   Asher, Craig R ^a   Popović, Zoran B ^a   Greenberg, Neil L ^a   Agler, Deborah A ^a   Drinko, Jeanne K ^a   Smedira, Nicholas G ^a   Tuzcu, E Murat ^a   Lytle, Bruce W ^a   Thomas, James D ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; ARTIFICIAL HEART PACEMAKER; CONTROLLED STUDY; DOPPLER ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; FEMALE; HEART LEFT BUNDLE BRANCH BLOCK; HEART LEFT VENTRICLE OUTFLOW TRACT; HEART MUSCLE CONDUCTION DISTURBANCE; HEART RIGHT BUNDLE BRANCH BLOCK; HUMAN; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MUSCLE RESECTION; PERCUTANEOUS CORONARY INTERVENTION; PERCUTANEOUS TRANSLUMINAL SEPTAL MYOCARDIAL ABLATION; PRIORITY JOURNAL; QRS COMPLEX; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

EID: 9144232514     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2003.09.034     Document Type: Article

References (26)

1. McCully R.B., Nishimura R.A., Tajik A.J., Schaff H.V., Danielson G.K. Extent of clinical improvement after surgical treatment of hypertrophic obstructive cardiomyopathy. Circulation. 94:1996;467-471.
2. Schulte H.D., Borisov K., Gams E., Gramsch-Zabel H., Losse B., Schwartzkopff B. Management of symptomatic hypertrophic obstructive cardiomyopathy-long-term results after surgical therapy. Thorac & Cardiovasc Surg. 47:1999;213-218.
3. Merrill W.H., Friesinger G.C., Graham T.P. Jr, Byrd B.F. III, Drinkwater D.C. Jr., Christian K.G., Bender H.W. Jr. Long-lasting improvement after septal myectomy for hypertrophic obstructive cardiomyopathy. Ann Thorac Surg. 69:2000;1732-1735.
4. Heric B., Lytle B.W., Miller D.P., Rosenkranz E.R., Lever H.M., Cosgrove D.M. Surgical management of hypertrophic obstructive cardiomyopathy. Early and late results. J Thorac Cardiovasc Surg. 110:1995;195-206.
5. Seggewiss H., Gleichmann U., Faber L., Fassbender D., Schmidt H.K., Strick S. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy acute results and 3-month follow-up in 25 patients . J Am Coll Cardiol. 31:1998;252-258.
6. Sigwart U. Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy. Lancet. 346:1995;211-214.
7. Knight C., Kurbaan A.S., Seggewiss H., Henein M., Gunning M., Harrington D., Fassbender D., Gleichmann U., Sigwart U. Nonsurgical septal reduction for hypertrophic obstructive cardiomyopathy outcome in the first series of patients . Circulation. 95:1997;2075-2081.
8. Lakkis N.M., Nagueh S.F., Dunn J.K., Killip D., Spencer W.H. III. Nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy one-year follow-up . J Am Coll Cardiol. 36:2000;852-855.
9. Spirito P., Maron B.J. Perspectives on the role of new treatment strategies in hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol. 33:1999;1071-1075.
10. Seggewiss H. Percutaneous transluminal septal myocardial ablation a new treatment for hypertrophic obstructive cardiomyopathy . Eur Heart J. 21:2000;704-707.
11. Seggewiss H., Faber L., Ziemssen P. Alcohol septal ablation for hypertrophic obstructive cardiomyopathy. Cardiol Rev. 7:1999;316-323.
12. Sasson Z., Yock P.G., Hatle L.K., Alderman E.L., Popp R.L. Doppler echocardiographic determination of the pressure gradient in hypertrophic cardiomyopathy. J Am Coll Cardiol. 11:1988;752-756.
13. Wagner G.S. Marriott's Practical Electrocardiography. 9th Ed :1994;Williams & Wilkins, Baltimore, MD. 86-95.
14. Henein M.Y., O'Sullivan C.A., Ramzy I.S., Sigwart U., Gibson D.G. Electromechanical left ventricular behavior after nonsurgical septal reduction in patients with hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol. 34:1999;1117-1122.
15. Kazmierczak J., Kornacewicz-Jach Z., Kisly M., Gil R., Wojtarowicz A. Electrocardiographic changes after alcohol septal ablation in hypertrophic obstructive cardiomyopathy. Heart. 80:1998;257-262.
16. Gietzen F.H., Leuner C.J., Raute-Kreinsen U., Dellmann A., Hegselmann J., Strunk-Mueller C., Kuhn H.J. Acute and long-term results after transcoronary ablation of septal hypertrophy (TASH). Catheter interventional treatment for hypertrophic obstructive cardiomyopathy. Eur Heart J. 20:1999;1342-1354.
17. Nagueh S.F., Lakkis N.M., He Z.X., Middleton K.J., Killip D., Zoghbi W.A., Quinones M.A., Roberts R., Verani M.S., Kleiman N.S., Spencer W.H. III. Role of myocardial contrast echocardiography during nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol. 32:1998;225-229.
18. Seggewiss H., Faber L., Gleichmann U. Percutaneous transluminal septal ablation in hypertrophic obstructive cardiomyopathy. Thorac Cardiovasc Surg. 47:1999;94-100.
19. Runquist L.H., Nielsen C.D., Killip D., Gazes P., Spencer W.H. III. Electrocardiographic findings after alcohol septal ablation therapy for obstructive hypertrophic cardiomyopathy. Am J Cardiol. 90:2002;1020-1022.
20. Singh M., Edwards W.D., Holmes D.R. Jr., TajiK A.J., Nishimura R.A. Anatomy of the first septal perforating artery a study with implications for ablation therapy for hypertrophic cardiomyopathy . Mayo Clin Proc. 76:2001;799-802.
21. Lakkis N.M., Nagueh S.F., Kleiman N.S., Killip D., He Z.X., Verani M.S., Roberts R., Spencer W.H. III. Echocardiography-guided ethanol septal reduction for hypertrophic obstructive cardiomyopathy. Circulation. 98:1998;1750-1755.
22. Brunner-La Schonbeck M.H., Rocca H.P., Vogt P.R., Lachat M.L., Jenni R., Hess O.M., Turina M.I. Long-term follow-up in hypertrophic obstructive cardiomyopathy after septal myectomy. Ann Thorac Surg. 65:1998;1207-1214.
23. Robbins R.C., Stinson E.B. Long-term results of left ventricular myotomy and myectomy for obstructive hypertrophic cardiomyopathy. J Thorac Cardiovasc Surg. 111:1996;586-594.
24. Faber L., Seggewiss H., Gleichmann U. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy results with respect to intraprocedural myocardial contrast echocardiography . Circulation. 98:1998;2415-2421.
25. Chang S.M., Nagueh S.F., Spencer W.H. III, Lakkis N.M. Complete heart block determinants and clinical impact in patients with hypertrophic obstructive cardiomyopathy undergoing nonsurgical septal reduction therapy . J Am Coll Cardiol. 42:2003;296-300.
26. Maron B.J., Merrill W.H., Freier P.A., Kent K.M., Epstein S.E., Morrow A.G. Long-term clinical course and symptomatic status of patients after operation for hypertrophic subaortic stenosis. Circulation. 57:1978;1205-1213.